Daniel O. Persky

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphoma

R. Fisher, T. Miller, M. Leblanc, 2013, Cancer.

AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B‐cell lymphomas

T. Miller, W. Qi, L. Cooke, 2012, International journal of cancer.